5-Amino-1MQ vs AOD-9604: What the Research Shows
5-Amino-1MQ and AOD-9604 side by side: what they are, how they are regulated and what is still unknown.
Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated
Quick verdict
Summary of studies, not a recommendationWhere the research points
Consider 5-Amino-1MQ if…
- you are tested in sport and want to avoid a WADA-prohibited substance: AOD-9604 is prohibited by WADA at all times (check 5-amino-1MQ's own status separately)[1]
Consider AOD-9604 if…
No sourced contrast for this side yet. We add a point here only when it is tied to a study or label.
What they have in common
- Only animal or lab studies of 5-amino-1MQ were found (e.g. obese mice): combined with a low-fat diet it promoted marked loss of adiposity and weight[2]
- Only animal or lab studies of AOD-9604 were found (e.g. rat): Oral AOD9604 for 19 days cut body weight gain by over 50% (15.8 g vs 35.6 g control) in obese Zucker rats.[8]
AOD-9604 is prohibited in tested sport (WADA). Status labels come from public FDA and WADA records; see the sources below.
Side by side
Spec comparison
Showing 7 of 13 fields where the two differ. Category, FDA status, PCAC vote, Jul 2026, Half-life, Evidence strength, Human studies we summarised are the same or both unknown.
| Field | 5-Amino-1MQ | AOD-9604 |
|---|---|---|
| Class | NNMT inhibitor (not a peptide) | HGH fragment analog |
| Also called | 5-amino, 1MQ | AOD |
| Category | GLP-1 & metabolic | GLP-1 & metabolic |
| FDA status | Not FDA approved · research chemical | Not FDA approved · research chemical |
| PCAC vote, Jul 2026 | Not on the Jul 2026 agenda | Not on the Jul 2026 agenda |
| WADA | WADA status unclear5-Amino-1MQ is not named. S4.4 covers AMPK activators, PPAR-delta agonists and Rev-erb agonists by example, and nothing there names an NNMT inhibitor. This is not named on the 2026 list. The catch-all class S0 prohibits any drug with no approval anywhere for human use, so it would be banned if no health authority has approved it, but we have not verified that for this substance. | Prohibited by WADA (S2.2.3)AOD-9604 is named as a growth hormone fragment in S2.2.3, prohibited at all times. |
| Anti-doping detection | None reportedanti-doping literature, as of 2 Oct 2026 |
|
| Half-life | No published half-life foundPubMed search, 2 Oct 2026 | No published half-life foundPubMed search, 2 Oct 2026 |
| Evidence strength | Animal evidence, 2 of 4Strongest: Scientific reports 2022, PMID 35013352 | Animal evidence, 2 of 4Strongest: Annals of clinical and laboratory science 2015, PMID 26275694 |
| Human studies we summarised | 0 human (0 randomized or controlled) of 4 summarised | 0 human (0 randomized or controlled) of 4 summarised |
| Typical study doses |
|
|
| Vial sizes sold | 5 mg, 10 mg | 2 mg, 5 mg, 10 mg |
| US searches per month | 27,100 · +60% searches | 18,100 · +31% searches |
Bracketed values are pending a sourced figure. Legal data reflects the regulatory events in our tracker.
Sources
- 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
- 2Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice.Scientific reports · 2022PMID 35013352Accessed 2 Oct 2026
- 3Small molecule inhibitor of nicotinamide N-methyltransferase shows anti-proliferative activity in HeLa cells.Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · 2021PMID 33645410Accessed 2 Oct 2026
- 4PubMed search: "5-amino-1MQ"[tiab] OR "5-amino-1-methylquinolinium"[tiab] (3 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 5PubMed search: nicotinamide N-methyltransferase[tiab] AND (quinolinium[tiab] OR 5-amino-1MQ[tiab] OR "5-amino-1-methylquinolinium"[tiab] OR 5MQ[tiab]) (6 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 6Detection and in vitro metabolism of AOD9604.Drug testing and analysis · 2015PMID 25208511Accessed 2 Oct 2026
- 7Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model.Annals of clinical and laboratory science · 2015PMID 26275694Accessed 2 Oct 2026
- 8Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone.Hormone research · 2000PMID 11146367Accessed 2 Oct 2026
- 9PubMed search: AOD9604[tiab] OR "AOD-9604"[tiab] OR "AOD 9604"[tiab] (22 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 10PubMed search: ("5-amino-1MQ"[tiab] OR 5-amino-1-methylquinolinium[tiab]) AND ("AOD-9604"[tiab] OR AOD9604[tiab])PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
Found an error? Report a correction.